Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018
In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to...
Saved in:
Published in | Journal of clinical microbiology Vol. 58; no. 11 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
21.10.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | In the early 2000s, a binary toxin (CDT)-producing strain of
, ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The
Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of
infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of
or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring).
was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of
were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 (
= 449; 29.5%). The epidemic CDT
RT027 (
= 2) and RT078 (
= 6), and the recently described RT251 (
= 10) and RT244 (
= 6) were not common, while RT126 (
= 17) was the most prevalent CDT
type. A heterogeneous
population was identified.
RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages. |
---|---|
AbstractList | In the early 2000s, a binary toxin (CDT)-producing strain of
Clostridium difficile
, ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The
C. difficile
Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of
C. difficile
infection (CDI) in Australia.
In the early 2000s, a binary toxin (CDT)-producing strain of
Clostridium difficile
, ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The
C. difficile
Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of
C. difficile
infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of
C. difficile
or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring).
C. difficile
was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of
C. difficile
were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 (
n
= 449; 29.5%). The epidemic CDT
+
RT027 (
n
= 2) and RT078 (
n
= 6), and the recently described RT251 (
n
= 10) and RT244 (
n
= 6) were not common, while RT126 (
n
= 17) was the most prevalent CDT
+
type. A heterogeneous
C. difficile
population was identified.
C. difficile
RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages. In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. ABSTRACT In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The C. difficile Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of C. difficile infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of C. difficile or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). C. difficile was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of C. difficile were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 ( n = 449; 29.5%). The epidemic CDT + RT027 ( n = 2) and RT078 ( n = 6), and the recently described RT251 ( n = 10) and RT244 ( n = 6) were not common, while RT126 ( n = 17) was the most prevalent CDT + type. A heterogeneous C. difficile population was identified. C. difficile RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages. In the early 2000s, a binary toxin (CDT)-producing strain of , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and Europe. This strain has not become established in Australia, and there is a markedly different repertoire of circulating strains there compared to other regions of the world. The Antimicrobial Resistance Surveillance (CDARS) study is a nationwide longitudinal surveillance study of infection (CDI) in Australia. Here, we describe the molecular epidemiology of CDI in Australian health care and community settings over the first 5 years of the study, 2013 to 2018. Between 2013 and 2018, 10 diagnostic microbiology laboratories from five states in Australia participated in the CDARS study. From each of five states, one private (representing community) and one public (representing hospitals) laboratory submitted isolates of or PCR-positive stool samples during two collection periods per year, February-March (summer/autumn) and August-September (winter/spring). was characterized by toxin gene profiling and ribotyping. A total of 1,523 isolates of were studied. PCR ribotyping yielded 203 different RTs, the most prevalent being RT014/020 ( = 449; 29.5%). The epidemic CDT RT027 ( = 2) and RT078 ( = 6), and the recently described RT251 ( = 10) and RT244 ( = 6) were not common, while RT126 ( = 17) was the most prevalent CDT type. A heterogeneous population was identified. RT014/020 was the most prevalent type found in humans with CDI. Continued surveillance of CDI in Australia remains critical for the detection of emerging strain lineages. |
Author | Hemphill, Christine Lahra, Monica Putsathit, Papanin George, Narelle Wehrhahn, Michael C Waring, Lynette Kotsanas, Despina Prendergast, Louise Wilson, Richard M Hong, Stacey Korman, Tony M Riley, Thomas V Huntington, Peter G Knight, Daniel R McDougall, Rodney Nimmo, Graeme R Moore, Casey V Robson, Jennifer Weldhagen, Gerhard F |
Author_xml | – sequence: 1 givenname: Stacey orcidid: 0000-0002-0482-7035 surname: Hong fullname: Hong, Stacey organization: Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia – sequence: 2 givenname: Papanin orcidid: 0000-0001-9789-4239 surname: Putsathit fullname: Putsathit, Papanin organization: School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia – sequence: 3 givenname: Narelle surname: George fullname: George, Narelle organization: Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia – sequence: 4 givenname: Christine surname: Hemphill fullname: Hemphill, Christine organization: Melbourne Pathology, Collingwood, VIC, Australia – sequence: 5 givenname: Peter G surname: Huntington fullname: Huntington, Peter G organization: Department of Microbiology, NSW Health Pathology, Royal North Shore Hospital, St Leonards, NSW, Australia – sequence: 6 givenname: Tony M surname: Korman fullname: Korman, Tony M organization: Monash Infectious Diseases, Monash University and Monash Health, Monash Medical Centre, Clayton, VIC, Australia – sequence: 7 givenname: Despina surname: Kotsanas fullname: Kotsanas, Despina organization: Monash Infectious Diseases, Monash University and Monash Health, Monash Medical Centre, Clayton, VIC, Australia – sequence: 8 givenname: Monica surname: Lahra fullname: Lahra, Monica organization: Department of Microbiology, The Prince of Wales Hospital, Randwick, NSW, Australia – sequence: 9 givenname: Rodney surname: McDougall fullname: McDougall, Rodney organization: Sullivan Nicolaides Pathology, Taringa, QLD, Australia – sequence: 10 givenname: Casey V surname: Moore fullname: Moore, Casey V organization: Microbiology and Infectious Diseases Laboratories, SA Pathology, Adelaide, SA, Australia – sequence: 11 givenname: Graeme R surname: Nimmo fullname: Nimmo, Graeme R organization: Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD, Australia – sequence: 12 givenname: Louise surname: Prendergast fullname: Prendergast, Louise organization: Melbourne Pathology, Collingwood, VIC, Australia – sequence: 13 givenname: Jennifer surname: Robson fullname: Robson, Jennifer organization: Sullivan Nicolaides Pathology, Taringa, QLD, Australia – sequence: 14 givenname: Lynette surname: Waring fullname: Waring, Lynette organization: Melbourne Pathology, Collingwood, VIC, Australia – sequence: 15 givenname: Michael C surname: Wehrhahn fullname: Wehrhahn, Michael C organization: Douglass Hanly Moir Pathology, Macquarie Park, NSW, Australia – sequence: 16 givenname: Gerhard F surname: Weldhagen fullname: Weldhagen, Gerhard F organization: Microbiology and Infectious Diseases Laboratories, SA Pathology, Adelaide, SA, Australia – sequence: 17 givenname: Richard M surname: Wilson fullname: Wilson, Richard M organization: Australian Clinical Labs, Microbiology Department, Wayville, SA, Australia – sequence: 18 givenname: Thomas V orcidid: 0000-0002-1351-3740 surname: Riley fullname: Riley, Thomas V email: Thomas.riley@uwa.edu.au organization: Department of Microbiology, PathWest Laboratory Medicine, Queen Elizabeth II Medical Centre, Nedlands, WA, Australia – sequence: 19 givenname: Daniel R orcidid: 0000-0002-9480-4733 surname: Knight fullname: Knight, Daniel R organization: Medical, Molecular and Forensic Sciences, Murdoch University, Murdoch, WA, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32848038$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1v1DAQhi1URLeFG2fkYw-b4q8kzgWpRLRbtIjDgsTNcuxxa5TYre1U2hN_nQ0tFZzmMI_eeTXPCToKMQBCbyk5p5TJ95_7L-eE1jWrGHmBVpR0smoa8uMIrQjp6opS3h6jk5x_EkKFqOtX6JgzKSThcoV-bfUQky4x7auPOoPFuzk9gB9HHQzg6HA_xlySt36esPXOeeNHwNfBgSk-BuwDvpgPhB69DngDeiy3uNcJsA4W93Ga5uDLHu-gFB9u8hozQjkucZnyNXrp9JjhzdM8Rd8vP33rN9X269V1f7GtDJeiVLWzouGuk7Xj1hGqDVAOnFJnpdBDq0U7mMYSZttOc8rF4EQDxljZDSAZ56fow2Pu3TxMYA2EpbG6S37Saa-i9ur_TfC36iY-qLaWLemWgLOngBTvZ8hFTT4bWP4Ecc6KCd5KwdpmQdePqEkx5wTu-QwlanGmDs7UH2eKkQP-7t9qz_BfSfw3Fu2VcA |
CitedBy_id | crossref_primary_10_1111_tid_13758 crossref_primary_10_3390_antibiotics12071141 crossref_primary_10_1128_aem_00379_23 crossref_primary_10_1111_jam_15408 crossref_primary_10_1128_MRA_00599_21 crossref_primary_10_1093_jpids_piab057 crossref_primary_10_1016_j_pathol_2021_10_009 crossref_primary_10_1093_ofid_ofad232 crossref_primary_10_1099_mgen_0_001232 crossref_primary_10_1128_spectrum_03582_22 crossref_primary_10_2807_1560_7917_ES_2022_27_49_2200244 crossref_primary_10_1093_jac_dkab099 crossref_primary_10_3390_microorganisms11071743 crossref_primary_10_1007_s10096_023_04569_x crossref_primary_10_1128_aac_00221_23 crossref_primary_10_1111_1462_2920_15821 crossref_primary_10_3390_genes13122200 |
Cites_doi | 10.15620/cdc:82532 10.1128/AEM.03032-14 10.5694/j.1326-5377.2011.tb03012.x 10.1016/j.anaerobe.2019.06.003 10.2807/1560-7917.es2015.20.10.21059 10.1093/jac/dkv220 10.1016/j.jinf.2016.05.010 10.1111/imj.13027 10.1093/cid/ciu203 10.1128/mBio.00446-19 10.1086/671728 10.1002/nmi2.43 10.1111/jam.13653 10.1016/j.anaerobe.2018.11.009 10.3201/eid1407.071641 10.1056/NEJMoa1910215 10.5694/mja13.11153 10.1038/srep41196 10.1016/j.anaerobe.2019.03.008 10.1086/592257 10.1128/CMR.00082-09 10.1016/j.pathol.2016.10.013 10.1017/s0950268800049323 10.3389/fmicb.2016.02138 10.1128/AEM.01888-13 10.1016/j.pathol.2016.02.005 10.1016/j.cmi.2017.10.008 10.1016/S0140-6736(10)61266-4 10.1016/j.ajic.2012.03.009 |
ContentType | Journal Article |
Copyright | Copyright © 2020 American Society for Microbiology. Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology |
Copyright_xml | – notice: Copyright © 2020 American Society for Microbiology. – notice: Copyright © 2020 American Society for Microbiology. 2020 American Society for Microbiology |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.1128/JCM.01552-20 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
DocumentTitleAlternate | Surveillance of Clostridium difficile in Australia |
EISSN | 1098-660X |
Editor | Diekema, Daniel J. |
Editor_xml | – sequence: 1 givenname: Daniel J. surname: Diekema fullname: Diekema, Daniel J. |
ExternalDocumentID | 10_1128_JCM_01552_20 32848038 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: ; grantid: RPG002-19 |
GroupedDBID | --- .55 0R~ 18M 29K 2WC 39C 4.4 53G 5GY 5RE 5VS ABOCM ABPPZ ACGFO ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CS3 D-I DIK DU5 E3Z EBS F5P FRP GX1 H13 HYE HZ~ KQ8 L7B NPM O9- OK1 P2P P6G RHF RHI RNS RPM RSF TR2 UCJ W8F WOQ X7M ZCA ~KM AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c384t-5fd463f985f3df01ace13e311fd84ab7a47bc6d02d79a3134bf46eccd89be8233 |
IEDL.DBID | RPM |
ISSN | 0095-1137 |
IngestDate | Tue Sep 17 21:11:18 EDT 2024 Fri Oct 25 03:59:47 EDT 2024 Thu Sep 12 16:33:26 EDT 2024 Sat Sep 28 08:28:06 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | molecular epidemiology surveillance Clostridium difficile ribotyping |
Language | English |
License | Copyright © 2020 American Society for Microbiology. All Rights Reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c384t-5fd463f985f3df01ace13e311fd84ab7a47bc6d02d79a3134bf46eccd89be8233 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Citation Hong S, Putsathit P, George N, Hemphill C, Huntington PG, Korman TM, Kotsanas D, Lahra M, McDougall R, Moore CV, Nimmo GR, Prendergast L, Robson J, Waring L, Wehrhahn MC, Weldhagen GF, Wilson RM, Riley TV, Knight DR. 2020. Laboratory-based surveillance of Clostridium difficile infection in Australian health care and community settings, 2013 to 2018. J Clin Microbiol 58:e01552-20. https://doi.org/10.1128/JCM.01552-20. Present address: Peter G. Huntington, Department of Microbiology, The Prince of Wales Hospital, Randwick, NSW, Australia. |
ORCID | 0000-0001-9789-4239 0000-0002-9480-4733 0000-0002-1351-3740 0000-0002-0482-7035 |
OpenAccessLink | https://doi.org/10.1128/jcm.01552-20 |
PMID | 32848038 |
PQID | 2437842763 |
PQPubID | 23479 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_7587093 proquest_miscellaneous_2437842763 crossref_primary_10_1128_JCM_01552_20 pubmed_primary_32848038 |
PublicationCentury | 2000 |
PublicationDate | 20201021 |
PublicationDateYYYYMMDD | 2020-10-21 |
PublicationDate_xml | – month: 10 year: 2020 text: 20201021 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | Journal of clinical microbiology |
PublicationTitleAlternate | J Clin Microbiol |
PublicationYear | 2020 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | Australian Comission on Safety and Quality in Health Care (e_1_3_3_10_2) 2018 e_1_3_3_17_2 e_1_3_3_16_2 e_1_3_3_19_2 e_1_3_3_18_2 e_1_3_3_12_2 Huber CA (e_1_3_3_13_2) 2014; 38 e_1_3_3_15_2 De Almeida MN (e_1_3_3_21_2) 2013; 126 e_1_3_3_34_2 e_1_3_3_14_2 e_1_3_3_32_2 e_1_3_3_33_2 e_1_3_3_11_2 e_1_3_3_30_2 Australian Commission on Safety and Quality in Health Care (e_1_3_3_5_2) 2011 e_1_3_3_31_2 e_1_3_3_6_2 e_1_3_3_8_2 e_1_3_3_7_2 e_1_3_3_28_2 e_1_3_3_9_2 e_1_3_3_27_2 e_1_3_3_29_2 e_1_3_3_24_2 e_1_3_3_23_2 e_1_3_3_26_2 e_1_3_3_25_2 e_1_3_3_2_2 e_1_3_3_20_2 e_1_3_3_4_2 e_1_3_3_22_2 e_1_3_3_3_2 |
References_xml | – ident: e_1_3_3_3_2 doi: 10.15620/cdc:82532 – ident: e_1_3_3_14_2 doi: 10.1128/AEM.03032-14 – ident: e_1_3_3_18_2 doi: 10.5694/j.1326-5377.2011.tb03012.x – ident: e_1_3_3_29_2 doi: 10.1016/j.anaerobe.2019.06.003 – ident: e_1_3_3_7_2 doi: 10.2807/1560-7917.es2015.20.10.21059 – ident: e_1_3_3_9_2 doi: 10.1093/jac/dkv220 – ident: e_1_3_3_28_2 doi: 10.1016/j.jinf.2016.05.010 – ident: e_1_3_3_33_2 doi: 10.1111/imj.13027 – ident: e_1_3_3_20_2 doi: 10.1093/cid/ciu203 – ident: e_1_3_3_22_2 doi: 10.1128/mBio.00446-19 – ident: e_1_3_3_31_2 doi: 10.1086/671728 – ident: e_1_3_3_19_2 doi: 10.1002/nmi2.43 – ident: e_1_3_3_26_2 doi: 10.1111/jam.13653 – ident: e_1_3_3_8_2 doi: 10.1016/j.anaerobe.2018.11.009 – ident: e_1_3_3_24_2 doi: 10.3201/eid1407.071641 – ident: e_1_3_3_4_2 doi: 10.1056/NEJMoa1910215 – ident: e_1_3_3_6_2 doi: 10.5694/mja13.11153 – volume: 38 start-page: E279 year: 2014 ident: e_1_3_3_13_2 article-title: Surveillance snapshot of Clostridium difficile infection in hospitals across Queensland detects binary toxin producing ribotype UK 244 publication-title: Commun Dis Intell Q Rep contributor: fullname: Huber CA – ident: e_1_3_3_27_2 doi: 10.1038/srep41196 – ident: e_1_3_3_30_2 doi: 10.1016/j.anaerobe.2019.03.008 – volume: 126 start-page: 9 year: 2013 ident: e_1_3_3_21_2 article-title: Severe Clostridium difficile infection in New Zealand associated with an emerging strain, PCR-ribotype 244 publication-title: N Z Med J contributor: fullname: De Almeida MN – ident: e_1_3_3_23_2 doi: 10.1086/592257 – ident: e_1_3_3_2_2 doi: 10.1128/CMR.00082-09 – volume-title: Implementation guide for surveillance of Clostridium difficile infection year: 2011 ident: e_1_3_3_5_2 contributor: fullname: Australian Commission on Safety and Quality in Health Care – ident: e_1_3_3_12_2 doi: 10.1016/j.pathol.2016.10.013 – ident: e_1_3_3_32_2 doi: 10.1017/s0950268800049323 – ident: e_1_3_3_15_2 doi: 10.3389/fmicb.2016.02138 – volume-title: Clostridium difficile infection. Monitoring the national burden of Clostridium difficile year: 2018 ident: e_1_3_3_10_2 contributor: fullname: Australian Comission on Safety and Quality in Health Care – ident: e_1_3_3_25_2 doi: 10.1128/AEM.01888-13 – ident: e_1_3_3_11_2 doi: 10.1016/j.pathol.2016.02.005 – ident: e_1_3_3_17_2 doi: 10.1016/j.cmi.2017.10.008 – ident: e_1_3_3_16_2 doi: 10.1016/S0140-6736(10)61266-4 – ident: e_1_3_3_34_2 doi: 10.1016/j.ajic.2012.03.009 |
SSID | ssj0014455 |
Score | 2.4787672 |
Snippet | In the early 2000s, a binary toxin (CDT)-producing strain of
, ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in North America and... In the early 2000s, a binary toxin (CDT)-producing strain of Clostridium difficile , ribotype 027 (RT027), caused extensive outbreaks of diarrheal disease in... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
SubjectTerms | Bacteriology |
Title | Laboratory-Based Surveillance of Clostridium difficile Infection in Australian Health Care and Community Settings, 2013 to 2018 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/32848038 https://search.proquest.com/docview/2437842763 https://pubmed.ncbi.nlm.nih.gov/PMC7587093 |
Volume | 58 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB51K1H1gqC8lkJlJLjh3fiR2DnCiqoUFoFKpd4iJ7bVlXaTaptF2lP_OmMnKS3cOOWQ2IryjeYRfzMfwFvFWCm4clTz0lCJBQANY-Bo7rmRutK2NKFReP4tOzmXpxfpxQ6kQy9MJO1X5WJSL1eTenEZuZVXq2o68MSm3-czzHEVVuLTEYzQQIcSvT86kDLtZAvylDIm1MB253p6OptP4swxtI192BPomnUSOlPuhqR_8sy_6ZJ34s_xI3jYJ47kQ_eCj2HH1QfwoJOS3B7A3rw_JH8CN187YJv1ln7EIGXJ2Wb9ywV5IUSYNJ7Mlk2Q67CLzYoEhRRcuHTkc8_LqsmiJn_-gZCuU4mETiViakv6npJ2S85cZE1fvycY4AVpm3DVT-H8-NPP2QntdRZoJbRsaeqtzITPdeqF9QkzlYv_Rpm3WppSGanKKrMJtyo3gglZepkh9FbnpdNciGewWze1ewHEeuVYag16ERnEy02O3jYxxuG2PKvcGN4Nn7q46sZpFLEM4bpAdIqITsGTMbwZcCjQ3sMhhqlds7kuwgBFLTm6xTE873C53WkAdAzqHmK3D4RZ2vfvoInFmdq9Sb3875WHsM9DKY5hjbNXsNuuN-415itteQSjLz_0UbTS304i6yg |
link.rule.ids | 230,315,730,783,787,888,27938,27939,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIkovPEppl6eR4Iazie0kzhFWVNuyqZDaot4iO3bEit2k2iZIy4W_zjiP0pYTnHJwbCWa8Tzsb74BeBsHgeYstlQyrajABIA6GjiaFEwJmUujlSsUTo-j6Zk4Og_PNyAcamFa0H6u5165WHrl_FuLrbxY5uMBJzb-kk4wxo0xEx_fgbu4X_1oSNL7ywMhwq5xQRLSIODxgHdncnw0Sb2WdQy1Yxu2OBpn6bvalOtO6a9I8zZg8poHOngIX4dv74An372m1l7-8xat4z__3CN40Mek5EM3_Bg2bLkD97oulesd2Er7-_cn8GvW6Uy1WtOP6P8MOWlWP6zrXITKQ6qCTBaV6wRi5s2SuOYrOHFhyWEP-SrJvCR_jldIVwRFXBEUUaUhfblKvSYntgVkX74nGDtwUlfuKXfh7ODT6WRK-xYONOdS1DQsjIh4kciw4KbwA5Xb9tg1KIwUSsdKxDqPjM9MnCgecKELEaFWGZloKxnnT2GzrEq7D8QUsQ1Co9BACdcXXSVoyH2lLC7LotyO4N0gw-yiY-rI2gyHyQzFnrViz5g_gjeDgDPcSu5-RJW2ai4zx80oBUOLO4K9TuBXKw2aMoL4hipcveBoum-OoIBbuu5eoM_-e-ZruD89TWfZ7PD483PYZi7jR-_JghewWa8a-xLDolq_ajfBbyHADEE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5BEateeJTX8jQS3MjLdhLnCAurtnSrSqVSxSWyY1us2E1W2wRpufDXGedRtuXWUw6xrUQznof9zXwA79IoUoymxhNUSY9jAuC5NnBeZqnkohBaSVcoPDtO9s_44Xl8vkX11YL2CzX3y8XSL-c_WmzlalkEA04sOJlNMMZNMRMPVtoGt-EO7tlQDIl6f4HAedyRF2SxF0UsHTDvVASHk5nfdh5DDdmFEUMDLUJXn7LtmP6LNq-DJre80PQ-fB--vwOf_PSbWvnF72utHW_0gw_gXh-bko_dkIdwy5R7cLdjq9zswWjW38M_gj9Hne5U6433Cf2gJqfN-pdxDEaoRKSyZLKoHCOInjdL4khYcOLCkIMe-lWSeUn-HbOQrhiKuGIoIktN-rKVekNOTQvMvvhAMIZgpK7cUzyGs-mXb5N9r6dy8AomeO3FVvOE2UzElmkbRrIw7fFrZLXgUqWSp6pIdEh1mkkWMa4sT1C7tMiUEZSxJ7BTVqV5BkTb1ESxlmiouONHlxka9FBKg8vSpDBjeD_IMV91HTvyNtOhIkfR563ocxqO4e0g5By3lLsnkaWpmovc9WgUnKLlHcPTTuiXKw3aMob0ijpcDnDtuq--QSG3bbt7oT6_8cw3MDr5PM2PDo6_voBd6hJ_dKI0egk79boxrzA6qtXrdh_8BY09DsE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Laboratory-Based+Surveillance+of+Clostridium+difficile+Infection+in+Australian+Health+Care+and+Community+Settings%2C+2013+to+2018&rft.jtitle=Journal+of+clinical+microbiology&rft.au=Hong%2C+Stacey&rft.au=Putsathit%2C+Papanin&rft.au=George%2C+Narelle&rft.au=Hemphill%2C+Christine&rft.date=2020-10-21&rft.issn=0095-1137&rft.eissn=1098-660X&rft.volume=58&rft.issue=11&rft_id=info:doi/10.1128%2FJCM.01552-20&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JCM_01552_20 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0095-1137&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0095-1137&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0095-1137&client=summon |